HUTCHMED (China) (HMDCF) Accumulated Depreciation (2014 - 2022)
HUTCHMED (China)'s (HMDCF) quarterly Accumulated Depreciation came in at $36.9 million in Q4 2022, up 12.05% year-over-year from $32.9 million in Q4 2021, and up 12.05% quarter-over-quarter from $32.9 million in Q4 2021.
Analysis
HUTCHMED (China) (HMDCF) Accumulated Depreciation (2014 - 2022) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Accumulated Depreciation for 9 consecutive years, with $36.9 million the latest figure, recorded in Q4 2022.
- On a quarterly basis, Accumulated Depreciation rose 12.05% year-over-year to $36.9 million in Q4 2022; TTM through Dec 2022 was $36.9 million, a 12.05% increase from a year earlier, with the FY2022 full-year figure at $36.9 million, up 12.05% from the prior year.
- Accumulated Depreciation was $36.9 million for Q4 2022 at HUTCHMED (China), up from $32.9 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $36.9 million in Q4 2022 and troughed at $19.3 million in Q2 2018.
- A 5-year average of $26.4 million and a median of $24.8 million in 2019 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation increased 25.18% in 2021 and gained 12.05% in 2022, its largest moves.
- Over 5 years, Accumulated Depreciation stood at $19.8 million in 2018, then gained by 17.78% to $23.4 million in 2019, then grew by 12.54% to $26.3 million in 2020, then advanced by 25.18% to $32.9 million in 2021, then grew by 12.05% to $36.9 million in 2022.
- The last three Accumulated Depreciation figures came in at $36.9 million (Q4 2022), $32.9 million (Q4 2021), and $26.3 million (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 36.86 Mn |
| Dec 31, 2021 | 32.90 Mn |
| Dec 31, 2020 | 26.28 Mn |
| Dec 31, 2019 | 23.35 Mn |
| Dec 31, 2018 | 19.83 Mn |
| Jun 30, 2018 | 19.33 Mn |
| Dec 31, 2017 | 17.49 Mn |
| Jun 30, 2017 | 15.91 Mn |
| Dec 31, 2016 | 14.40 Mn |
| Jun 30, 2016 | 14.03 Mn |
| Dec 31, 2015 | 13.34 Mn |
| Dec 31, 2014 | 12.50 Mn |